144 related articles for article (PubMed ID: 37917089)
1. Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer.
McVicker L; Labeit AM; Coupland CAC; Hicks B; Hughes C; McMenamin Ú; McIntosh SA; Murchie P; Cardwell CR
JAMA Oncol; 2024 Jan; 10(1):103-108. PubMed ID: 37917089
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
4. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
6. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
9. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
Inayama Y; Mizuno K; Yamaguchi K; Hamanishi J; Takeuchi M; Egawa M; Mandai M; Kawakami K
J Obstet Gynaecol Res; 2023 Jul; 49(7):1805-1814. PubMed ID: 37029559
[TBL] [Abstract][Full Text] [Related]
11. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
[TBL] [Abstract][Full Text] [Related]
12. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Beral V; Reeves G; Bull D; Green J;
J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017.
Akter N; Kulinskaya E; Steel N; Bakbergenuly I
BJOG; 2022 May; 129(6):994-1003. PubMed ID: 34773357
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper.
Ranger TA; Burchardt J; Clift AK; Mei WX; Coupland C; Tan PS; Dixon S; Cardwell CR; Hippisley-Cox J
BMJ Open; 2021 Aug; 11(8):e046701. PubMed ID: 34341043
[TBL] [Abstract][Full Text] [Related]
16. Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.
Bhupathiraju SN; Grodstein F; Stampfer MJ; Willett WC; Crandall CJ; Shifren JL; Manson JE
Menopause; 2018 Dec; 26(6):603-610. PubMed ID: 30562320
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
20. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.
Hunt K; Vessey M; McPherson K
Br J Obstet Gynaecol; 1990 Dec; 97(12):1080-6. PubMed ID: 2126197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]